Argenx
ARGX
#405
Rank
S$80.89 B
Marketcap
S$1,301
Share price
0.02%
Change (1 day)
43.47%
Change (1 year)
Argenx is a Dutch company that develops antibody therapies to fight autoimmune diseases and cancer.

EPS for Argenx (ARGX)

EPS in 2026 (TTM): S$20.50

According to Argenx 's latest financial reports the company's current EPS (TTM) is S$20.10. In 2025 the company made an earnings per share (EPS) of S$26.80 an increase over its 2024 EPS that were of S$17.69.

EPS history for Argenx from 2011 to 2026

Annual EPS

Year EPS Change
2026 (TTM)S$20.50-23.48%
2025S$26.8051.44%
2024S$17.69-369.77%
2023S-$6.56-60.46%
2022S-$16.5963.33%
2021S-$10.16-40.37%
2020S-$17.03183.47%
2019S-$6.01123.09%
2018S-$2.6954.93%
2017S-$1.7414.07%
2016S-$1.5213.05%
2015S-$1.35-36.34%
2014S-$2.12209.04%
2013S-$0.69-33.99%
2012S-$1.04185.59%
2011S-$0.36